In Brief: Bradley Pharmaceuticals

This article was originally published in The Tan Sheet

20 May 1996
News

The Tan Sheet

Executive Summary

Bradley Pharmaceuticals: Acquires Acid Mantle skin treatment line from Sandoz, Fairfield, N.J.-based Bradley announced May 9. Purchased for less than $1 mil., the line will be marketed by Bradley's Doak Dermatologics subsidiary. Distribution of Acid Mantle with hydrocortisone will begin in the third quarter with accompanying advertising, promotion and sampling efforts. Additional line extensions are planned to follow, the company stated. Other Doak product lines include Carmol body lotions and Formula 405 skin care products...

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
Consumer
Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS085394

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS085394

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

In Brief: Bradley Pharmaceuticals

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert